Skip to main content

Welcome New Corporate Partners (April/May 2024)

Welcome Immunocore and Xeris

The HBA is proud to welcome new corporate partners to help lead the charge for furthering the advancement and impact of women in the business of healthcare. It’s these bold companies who are seen as an employer of choice for women and top talent.

As we welcome these new companies to our United Force for Change community, let’s learn a little more about them:

CEO: Bahija Jallal

Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world’s first approved T cell receptor (TCR) therapy. Our mission is to radically improve outcomes for patients with cancer, infectious diseases, and autoimmune diseases, by pioneering and delivering transformative immunomodulating medicines.

Xeris Pharmaceuticals
CEO: Paul Edick

A growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.

To learn more about Corporate Partner Benefits please click here